Roivant Sciences Ltd. Common Shares (ROIV)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 721
- Market Cap
- $24.9B
About Roivant Sciences Ltd. Common Shares
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
SentiSense also tracks daily options readings for Roivant Sciences Ltd. Common Shares: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Roivant Sciences Ltd. Common Shares stock analysis, sentiment tracking, and market intelligence on SentiSense.